acetohydroxamic acid and su 11248

acetohydroxamic acid has been researched along with su 11248 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JY; Fields, GB; Hart, PJ; Hodder, PS; Jiang, J; Minond, D; Roush, WR; Spicer, TP; Taylor, AB1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for acetohydroxamic acid and su 11248

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for acetohydroxamic acid and su 11248

ArticleYear
Characterization of selective exosite-binding inhibitors of matrix metalloproteinase 13 that prevent articular cartilage degradation in vitro.
    Journal of medicinal chemistry, 2014, Nov-26, Volume: 57, Issue:22

    Topics: Animals; Binding Sites; Cartilage; Cartilage, Articular; Cattle; Chemistry, Pharmaceutical; Collagen; Collagenases; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Drug Design; Humans; Hydrolysis; Inhibitory Concentration 50; Kinetics; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Mice; Microsomes; Molecular Conformation; Osteoarthritis; Protein Binding; Protein Conformation; Rats; Structure-Activity Relationship

2014